Cue Biopharma, Inc. (CUE)
4.32
-0.18
(-4.00%)
USD |
NASDAQ |
Nov 20, 12:02
Cue Biopharma Free Cash Flow : -51.22M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -51.22M |
| June 30, 2026 | -50.17M |
| March 31, 2026 | -24.60M |
| December 31, 2025 | -21.86M |
| September 30, 2025 | -29.82M |
| June 30, 2025 | -28.32M |
| March 31, 2025 | -34.88M |
| December 31, 2024 | -36.40M |
| September 30, 2024 | -38.32M |
| June 30, 2024 | -38.60M |
| March 31, 2024 | -38.97M |
| December 31, 2023 | -39.96M |
| September 30, 2023 | -39.52M |
| June 30, 2023 | -38.67M |
| March 31, 2023 | -41.21M |
| December 31, 2022 | -41.98M |
| September 30, 2022 | -42.11M |
| Date | Value |
|---|---|
| June 30, 2022 | -41.80M |
| March 31, 2022 | -38.91M |
| December 31, 2021 | -39.75M |
| September 30, 2021 | -36.21M |
| June 30, 2021 | -37.61M |
| March 31, 2021 | -34.59M |
| December 31, 2020 | -33.09M |
| September 30, 2020 | -32.43M |
| June 30, 2020 | -33.62M |
| March 31, 2020 | -33.29M |
| December 31, 2019 | -30.84M |
| September 30, 2019 | -28.41M |
| June 30, 2019 | -25.79M |
| March 31, 2019 | -26.33M |
| December 31, 2018 | -28.27M |
| September 30, 2018 | -26.16M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cypherpunk Technologies, Inc. | -132.19M |
| Yarrow Bioscience, Inc. | -99.79M |
| Faeth Therapeutics, Inc. | -43.28M |
| Indaptus Therapeutics, Inc. | -13.97M |
| Pyxis Oncology, Inc. | -70.93M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -10.08M |
| Cash from Financing (Quarterly) | 50.63M |
| Free Cash Flow Per Share (Quarterly) | -0.9546 |
| Free Cash Flow to Equity (Quarterly) | -10.40M |
| Free Cash Flow to Firm (Quarterly) | -10.08M |
| Free Cash Flow Yield | -152.9% |